GSK Investigational Site

Красноярск 660049

0 studies enrolling now · 4 studies all time

What they study most

HIV Infections, Hepatitis B, Infection, Human Immunodeficiency Virus

Studies at this site

• Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) — Running, not enrolling
• Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) — Completed
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) — Completed
• A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) — Completed